Pathophysiology of bone loss in patients receiving anticonvulsant therapy (Q47660371)

4 February 2018

title

Pathophysiology of bone loss in patients receiving anticonvulsant therapy (English)

1 reference

4 February 2018

0 references

1 reference

Lorraine A Fitzpatrick

series ordinal

1

1 reference

4 February 2018

publication date

1 February 2004

1 reference

4 February 2018

published in

Epilepsy Behavior

1 reference

4 February 2018

volume

5 Suppl 2

1 reference

4 February 2018

page(s)

S3-15

1 reference

4 February 2018

Removal of calcium from bone as influenced by the parathyroids

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Distribution of hormone-dependent adenylate cyclase in the nephron and its physiological significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

McCollum Award Lecture, 1994: vitamin D--new horizons for the 21st century

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

The Vitamin D Content of Fortified Milk and Infant Formula

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

The vitamin D story: a collaborative effort of basic science and clinical medicine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

The role of the vitamin D endocrine system in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Lifetime occupational physical activity and risk of hip fracture in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Fracture risk is increased in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Osteomalacia with Long-term Anticonvulsant Therapy in Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Disturbance of Calcium Metabolism by Anticonvulsant Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Altered Calcium Metabolism in Epileptic Children on Anticonvulsants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Antiepileptic Drugs and Vitamin D Supplementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Incidence of five common fracture types in an institutional epileptic population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Do Anticonvulsant Drugs Commonly Induce Osteomalacia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Calcium metabolism and vitamin D metabolite levels in children receiving anticonvulsant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Evidence of osteomalacia in an outpatient group of adult epileptics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Anticonvulsant drugs and bone metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Factors associated with the biochemical changes in vitamin D and calcium metabolism in institutionalized patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Antiepileptic drug-induced bone loss in young male patients who have seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Calcium balance in drug-induced osteomalacia: Response to vitamin D

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Hydroxylase enzymes of the vitamin D pathway: expression, function, and regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Absorption and Biotransformation of Cholecalciferol in Drug-Induced Osteomalacia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Phenobarbital-induced alterations in vitamin D metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Cloning and expression of cDNA encoding 25-hydroxyvitamin D3 24-hydroxylase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Genetics of vitamin D 1alpha-hydroxylase deficiency in 17 families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Bone density and long-term anticonvulsant therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Bone density in patients receiving long-term anticonvulsant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Secondary causes of osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Vitamin D-dependent rickets in institutionalized, mentally retarded children receiving long-term anticonvulsant therapy. I. A survey of 288 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Effect of antiepileptic drugs on bone density in ambulatory patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Vitamin D insufficiency among free-living healthy young adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Hepatic enzyme induction and vitamin K1 elimination in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Phenytoin affects osteocalcin secretion from osteoblastic rat osteosarcoma 172.8 cells in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

The Antihæmorrhagic Vitamin of the Chick.: Occurrence And Chemical Nature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Effects of vitamin K on calcium and bone metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Increased bone formation in osteocalcin-deficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Effects of phenytoin and/or vitamin K2 (menatetrenone) on bone mineral density in the tibiae of growing rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Diphenylhydantoin inhibition of calcitonin secretion in the pig.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Changes in bone turnover and deoxypyridinoline levels in epileptic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Bone density and antiepileptic drugs: a case-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Phenytoin at micromolar concentrations is an osteogenic agent for human-mandible-derived bone cells in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Phenytoin and its metabolite, 5-(4-hydroxyphenyl)-5-phenylhydantoin, show bone resorption in cultured neonatal mouse calvaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Interaction of Diphenylhydantoin (Phenytoin) and Phenobarbital with Hormonal Mediation of Fetal Rat Bone Resorption In Vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

The effect of phenytoin on parathyroid hormone stimulated cAMP activity in cultured murine osteoblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

Osteogenic actions of phenytoin in human bone cells are mediated in part by TGF-beta 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.026

10.1016/J.YEBEH.2003.11.026

7 January 2021

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

15123006

1 reference

4 February 2018